Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer

NCT00096304 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

36

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Prostate Cancer

Interventions

DRUG: docetaxel
DRUG: epirubicin hydrochloride

Sponsor

Medical University of South Carolina